NCT04183166TG4050Mayo ClinicHNSCCSouth Central - Oxford
…Background In the phase I trial TG4050.02 ( NCT04183166) evaluating TG4050 in resected, locally advanced HNSCC patients…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 2,461–2,520 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
North East - York Research Ethics Committee1North East Ambulance Service NHS Foundation Trust1North East England food aid organisations1North London NHS Foundation Trust1North Tees & Hartlepool NHS Foundation Trust1North West Anglia NHS Foundation Trust1North West Greater Manchester Research Ethics Committee1North West Multi-Centre Research Ethics Committee1North of Scotland Research Ethics Committee1Northern Care Alliance NHS Foundation Trust1Northern Ireland Ambulance Service1Northern Ireland Fire and Rescue Service1Northern Irish (UK) Health and Social Care Trusts1Norwegian Labour and Welfare Administration1Norwegian Olympic and Paralympic Committee1Norwegian hospital trust1Nottingham University Hospitals NHS Trust1Nottingham University Hospitals Trust1Nottinghamshire Healthcare NHS Foundation Trust1Novartis Pharma AG1Nr. BE-2–531Nuffield Trust1OCHA1OECD countries1OMB-OMB1OMON1OMON-registry1OPEN Health Communications1OPTIKNEE1Oasis1Obstetric Anaesthetists’ Association1Ocean Youth Trust1Office for Ageing Well1Office for Budget Responsibility1Office for Health Improvement & Disparities1Office of Management and Budget1Office of National Statistics1Official Development Assistance for Health1Oklahoma Medical Marijuana Authority1Oklahoma State Department of Health1Olivia Hodson Cancer Fund1Oncology Research Information Exchange Network1Oncology Service1OneFlorida+ Clinical Research Consortium1Open Science Foundation1Operational Delivery Network1Optum Clinformatics Data Mart1Optum Market Clarity Database1Orbital Society1Oregon Judicial Department1Organisation for Economic Co-operation and Development Convention1Organisation for Economic Co-operation and Development Creditor Reporting System1Organisation for Economic Cooperation and Development1Organization for Economic Cooperation and Development1Organization for Economic Cooperation and Development Creditor Reporting System1Organization for Human Brain Mapping1Oromia Regional Health Bureau1Osteoarthritis Initiative1Ottawa Health Science Network Research Ethics Board1Ovid-MEDLINER1
Articles mentioning funders
5,089 articles · page 330 of 425NCT04162015nivolumabDiffuse pleural mesotheliomapemetrexedcisplatincarboplatinplatinumP/D
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…
Bristol-Myers Squibbneoadjuvant immunotherapynivolumabEGFR-mutant NSCLCchemotherapyCTONG1104
…and families involved in this study. This work was supported by Bristol-Myers Squibb, Guangdong Provincial Key Lab of Translational Medicine in Lung…
Foundation for the National Institutes of Health, Inc.CAN-2409docetaxelNSCLCsacituzumab govitecanvalacyclovir
…oject was made possible through funding support provided to the Foundation for the National Institutes of Health, Inc. (FNIH) by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma…
AstraZenecadurvalumabcapivasertibDurvaolaparibOlaCaprelapse/refractory solid cancers
…ing macrophages and stromal cells are underway.Acknowledgements AstraZeneca’s support is gratefully acknowledgedTrial Registration NCT03772…
Astellas Pharma Inc.ASP1012la/m solid tumorsadvanced solid tumorsOxford PharmaGenesis Inc.
…uding 3×10 9 pfu/dose.Acknowledgements This study was funded by Astellas Pharma Inc. Medical writing support, conducted in accordance with Good Publ…
IRB00115160cemiplimabEmory Universitymetastatic cutaneous squamous cell carcinoma (CSCC)
…proval The study was approved by the Emory IRB (approval number IRB00115160) and participants gave informed consent to take part in this st…
FDAMitazalimabmFOLFIRINOX
… Journal for ImmunoTherapy of Cancer 2024;12(Suppl 2):A677–A678.FDA. Optimizing the dose of human prescription drugs and biological…
FDAEVOLVE104EIU-104101urothelial carcinomasquamous cell carcinomasCohort BCohort AEVOLVE TCEstransitional cell carcinomas of the urinary tractlocally advanced or metastatic solid tumors
…g.Ethics Approval Study EIU-104101 is currently under review by FDA and will only begin enrollment upon clearance from relevant hea…
American Surgical Association Research AwardAppendiceal cancerMD Anderson Cancer CenterBarnes-Jewish HospitalpaclitaxelUniversity of Texas MD Anderson Cancer Centercolorectal cancerWashington University Institutional Review Board
…cy.Acknowledgements This work was supported by funding from the American Surgical Association Research Award (Dr. Beth A. Helmink), NIH grant R37AI049653 (Dr. Gwendalyn J. …
PHASE ONE FoundationECOG Performance StatusDana-Farber Cancer InstituteIL-12myeloid leukemiaIL-15IL-18PROCpembrolizumabDana-Farber/Harvard Cancer Center+6 more
…uable. The authors are deeply grateful for funding support from PHASE ONE Foundation and from Pan-Mass Challenge Team Ovarian Cancer.References Disi…
Mount Sinai PPHS IRBHNSCCimmunotherapyMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)
…drivers of immunotherapy resistance among HNSCC.Ethics Approval Mount Sinai PPHS IRB approved STUDY-21-01683…